The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Large-scale manufacture of peptide therapeutics by chemical synthesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
FIELDS, G. B., & NOBLE, R. L. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,493
Stewart, J. M. (1976) · Journal of Macromolecular Science: Part A - Chemistry · doi:10.1080/00222337608068099 · Cited by 1,767
König, W., & Geiger, R. (1970) · Chemische Berichte · doi:10.1002/cber.19701030319 · Cited by 1,577
(2000) · Cited by 1,342
9-Fluorenylmethoxycarbonyl amino-protecting group
Carpino, L. A., & Han, G. Y. (1972) · The Journal of Organic Chemistry · doi:10.1021/jo00795a005 · Cited by 1,041
New coupling reagents in peptide chemistry
Knorr, R., Trzeciak, A., Bannwarth, W., & Gillessen, D. (1989) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)99616-3 · Cited by 996
Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin.
Rink, H. (1987) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)96384-6 · Cited by 857
9-Fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group
Carpino, L. A., & Han, G. Y. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00722a043 · Cited by 584
Principles of Peptide Synthesis
Bodanszky, M. (1993) · Springer eBooks · doi:10.1007/978-3-642-78056-1 · Cited by 438
Darstellung geschützter peptid-fragmente unter einsatz substituierter triphenylmethyl-harze
Barlos, K., Gatos, D., Kallitsis, J. K., Papaphotiu, G., Sotiriu, P., Wenqing, Y., & Schäfer, W. (1989) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)99290-6 · Cited by 305
Chang, C., & Meienhofer, J. (1978) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1978.tb02845.x · Cited by 304
A mild procedure for solid phase peptide synthesis: use of fluorenylmethoxycarbonylamino-acids
Atherton, E., Fox, H., Harkiss, D., Logan, C. J., Sheppard, R. C., & Williams, B. J. (1978) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39780000537 · Cited by 301
Prediction of difficult sequences in solid-phase peptide synthesis
Milton, R. C. D. L., Milton, S. C. F., & Adams, P. A. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00172a020 · Cited by 153
Cameron, L. R., Holder, J. L., Meldal, M., & Sheppard, R. C. (1988) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19880002895 · Cited by 63
Cited by
Rethinking amide bond synthesis
Pattabiraman, V. R., & Bode, J. W. (2011) · Nature · doi:10.1038/nature10702 · Cited by 2,164
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Lau, J. L., & Dunn, M. K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.052 · Cited by 1,879
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Metadata
- Authors
- Bray, B. L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-07
- Volume
- 2
- Issue
- 7
- Pages
- 587-593
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1529818809
- Cited by
- 598
- References
- 16
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.